Ravi Nagubandi, MD
Surgery · Oroville, CANPI 1962722850
Payments from drug & device makers
Across 72 payments — averaging $109.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$2K
- Acell, Inc.$2K
- Intuitive Surgical$1K
- Endogastric Solutions, Inc$1K
- TELA Bio, Inc.$863
- BD$309
- plus $373 from 12 others
What the payments were for
- Travel & lodging$5,46569%
- Food & beverage$2,44731%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 14 | $2,153 |
| Acell, Inc. | 11 | $1,668 |
| Intuitive Surgical | 13 | $1,473 |
| Endogastric Solutions, Inc | 6 | $1,072 |
| TELA Bio, Inc. | 6 | $863 |
| BD | 5 | $309 |
| Merck | 2 | $48 |
| Organogenesis Inc. | 2 | $46 |
| Enterra Medical, Inc. | 1 | $41 |
| Johnson & Johnson | 2 | $39 |
| Medela LLC | 2 | $38 |
| Integra Lifesciences Corporation | 2 | $34 |
| Lemaitre Vascular, Inc. | 1 | $31 |
| Shockwave Medical, Inc | 1 | $24 |
| Kerecis Limited | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| W. L. Gore & Associates, Inc. | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Phasix Mesh$1,470
- Da Vinci Surgical System$1,247
- ESOPHYX$936
- OviTex 2S$712
How this compares
$7,912 in reported general payments places this provider in the 70th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 14 | $2,194 |
| Anastrozole | 46 | $918 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $284 |
| Omeprazole | 30 | $206 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 15 | $189 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $173 |
| Metoclopramide Hcl | 15 | $17 |
Paid to pharmacies, not to this prescriber.
Other surgery in Oroville
- Timothy ChuterSan Francisco$8.9M
- Peter StockSan Francisco$6.5M
- Santiago HorganSan Diego$2.8M
- Kenneth DeckLaguna Hills$2.4M
- Daniel RiskinSan Jose$2.2M
- Michael DemeureNewport Beach$1.7M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.